SCHEMBL23263314

SCHEMBL23263314

CC(C)c1cccc(-c2cncc(F)c2)c(=O)c1OC(=O)OC(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 3/20 0.34
▸ CTPS1 P17812 1/20 0.33
▸ SCN5A Q14524 1/20 0.32
▸ SCN9A Q15858 1/20 0.32
▸ SCN10A Q9Y5Y9 1/20 0.32
▸ ABL1 P00519 1/20 0.32
▸ RPS6KB1 P23443 1/20 0.31
▸ CSNK1D P48730 1/20 0.31
▸ GSK3A P49840 1/20 0.31
▸ GSK3B P49841 1/20 0.31
▸ NTRK2 Q16620 1/20 0.31
▸ AURKB Q96GD4 1/20 0.31
▸ PARP10 Q53GL7 1/20 0.31
▸ PARP11 Q9NR21 1/20 0.31
▸ PTPN5 P54829 1/20 0.31
▸ LGMN Q99538 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23263317 0.85 CTPS1 (0.33) DYRK1ACTPS1ABL1RPS6KB1CSNK1D
SCHEMBL23263316 0.83 CTPS1 (0.32) DYRK1ACTPS1ABL1RPS6KB1CSNK1D
SCHEMBL23263935 0.81 CHRNB4 (0.40) DYRK1ACTPS1ABL1RPS6KB1CSNK1D
SCHEMBL29890449 0.79 CYP3A4 (0.41) DYRK1APARP10PARP11PTPN5
SCHEMBL23249843 0.79 CYP3A4 (0.41) DYRK1APARP10PARP11PTPN5
SCHEMBL23258467 0.78 SCN5A (0.40) SCN5ASCN9ASCN10A
SCHEMBL27018507 0.76 CTSA (0.37) DYRK1AABL1PARP10PARP11LGMN
SCHEMBL23258801 0.73 SCN5A (0.40) SCN5ASCN9ASCN10A
SCHEMBL23263161 0.72 PARP10 (0.35) DYRK1AABL1PARP10PARP11
SCHEMBL23263129 0.72 BACE1 (0.39) DYRK1ACTPS1ABL1RPS6KB1CSNK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021076945-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS Ambys Medicines, Inc. (US) 2021-04-22 — — WO disclosed
Send feedback